RxDoctor Payments Data

Scott Perlman, MD

Nuclear Imaging & Therapy · Madison, WINPI 1649248030

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $1,270 of the $1,349 with a category attached, or 94.1%. Pfizer accounts for 94.1% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2019 at $1,270 and has fallen 98.4% since, to $20 in 2025.

$1,349in general payments, 2019–2025

Across 4 payments — averaging $337.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$1K
  • Eisai Inc.$59
  • GE HealthCare$20
$3,200in research payments, 2019–2025

Across 1 payment — averaging $3200.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$3K

What the payments were for

  • Speaking & faculty fees$1,27094%
  • Food & beverage$796%

General payments by program year

19
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Pfizer2$1,270
Eisai Inc.1$59
GE HealthCare1$20

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few nuclear imaging & therapy providers in Wisconsinto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$695,460
Medicare patients
609
Services billed
1,705

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other nuclear imaging & therapy in Madison

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →